^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    prizloncabtagene autoleucel (JNJ-4496)

    i
    Other names: anti-CD19/20-CAR vector-transduced T cell therapy, anti-CD19/20 CART cell therapy, EXP039, CD19/CD20-directed CAR-T cells, C CAR039, EXP 039, JNJ 4496, JNJ 90014496, CCAR039, EXP-039, JNJ4496, JNJ90014496, JNJ-4496, JNJ-90014496, C-CAR039
    Company:
    AbelZeta Pharma, J&J, Tongji University
    Drug class:
    CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy
    Related drugs: